Weaver Allison, Rubinstein Samuel, Cornell Robert F
Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.
Front Oncol. 2020 May 19;10:815. doi: 10.3389/fonc.2020.00815. eCollection 2020.
Hyperviscosity syndrome is a serious complication associated with high levels of paraproteins in patients with hematological malignancies. Therapeutic advances in disease control may reduce the incidence of hyperviscosity syndrome; however, management of acute cases requires an understanding of key symptoms and prompt treatment to mitigate serious consequences.
高黏滞血症是血液系统恶性肿瘤患者中与高水平副蛋白相关的一种严重并发症。疾病控制方面的治疗进展可能会降低高黏滞血症的发生率;然而,急性病例的处理需要了解关键症状并及时治疗以减轻严重后果。